Etanercept biosimilar (Amega Biotech)

依那西普生物类似药 (Amega Biotech)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEtanercept biosimilar (Amega Biotech)

Drug Alias Name依那西普生物仿制药 (Amega Biotech)rhTNFR:Fc (Amega Biotech)TNFR:Fc (Amega Biotech)Recombinant etanercept - Amega BiotechEtanerceptum (Amega Biotech) +[12]

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar

Mechanisms of ActionTumor necrosis factor β inhibitorsTumor necrosis factor α inhibitors

TargetsTumor necrosis factor βTumor necrosis factor α

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsArthritis, Rheumatoid

Approved Indications in ChinaN/A

Original Approved Country/TerritoryArgentina

Original Approved Date2012/01/01

Country/TerritoryArgentina

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesAmega Biotech

China Registration ClassN/A

Develop Information

Active CompaniesAmega Biotech

Inactive CompaniesN/A

Active IndicationsArthritis, Rheumatoid

Inactive IndicationsN/A

Other Information

ATC CodeL04AB01